Nolato (NOLA B)

Nasdaq Stockholm | Industrials | Polymer-based contract manufacturing (medtech and industrial)
Intro rate Introductory pricing for early customers through June 30 — the same full analysis at a lower rate while we refine delivery.
Free
No email, no account, no signup.
Pulling latest news for Nolato…
Bull
Bear
Intro rate Introductory pricing for early customers through June 30 — the same full analysis at a lower rate while we refine delivery.

Professional stock analysis at introductory pricing. 7-day money-back guarantee — no lock-in.

Want the why behind the signal? Get the deep 4-model report — full bull/bear, dated catalysts, dilution risk, weekly refresh. $4.99 $1.25.
Get the deep 4-model report – $4.99 $1.25
Signal
HOLD
Sentiment
3/10
Risk
4/10
Get full analysis with Bull/Bear case, catalysts, and risk analysis
Buy express analysis – $4.99 $1.25
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Sentiment has weakened after the Q1 miss versus expectations and the sharp share-price reaction, despite stable margins and improved cash flow.
Exchange
Nasdaq Stockholm
Type
Industrials
Sector
Polymer-based contract manufacturing (medtech and industrial)
Market Cap
$1.4B

36 days ago 11 May 2026

Market sentiment

Sentiment has weakened after the Q1 miss versus expectations and the sharp share-price reaction, despite stable margins and improved cash flow.

Why HOLD ?

Hold: stable profitability and strong cash flow/balance sheet offset weaker reported sales and ongoing FX headwinds. After the large price move, risk/reward looks more balanced, but the risk of further quarterly disappointments remains until reported growth improves.
  • Hold; consider adding only after clearer evidence of a recovery in reported growth (FX/volumes) and confirmation that any ramp-up/start-up costs are not pressuring margins.

Recent News

  • Nolato reported Q1 2026 with net sales of SEK 2,357m (−3.9% YoY) and EBITA of SEK 260m (271), with the EBITA margin unchanged at 11.0%. Operating cash flow improved to SEK 225m (135) and net debt remained low. By segment, Medical Solutions and Materials delivered organic growth, while currency headwinds weighed on reported figures. The share fell about 16% on the results day. The AGM on 6 May approved a SEK 1.70/share dividend (ex 8 May, pay date 13 May) and board changes.

Bull case

- **Q1 earnings** may confirm Q4 margin pressure was temporary - **Dividend/AGM** can support the stock via a stable cash-flow narrative - **Confidence boost** if Hungary ramp-up/validation updates are positive
Unlock to read more →

Bear case

- **Continued sales softness** could trigger further negative reactions - **FX and cost headwinds** may keep margins under pressure - **Start-up costs** (new programs) could weigh for additional quarters
Unlock to read more →

Catalysts

15 Aug 2026 — Malaysia production start

Unlock 2 more catalysts →

Dilution Risk

Assessment: Low

Order analysis – $4.99 $1.25
Save hours of research. $4.99 $1.25.
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Intro rate Introductory pricing for early customers through June 30 — the same full analysis at a lower rate while we refine delivery.

Want to read the full analysis?

Order a fresh analysis of Nolato – ready in your inbox in 5–15 minutes.

  • Signal + risk + sentiment
  • Bull/Bear case + triggers
  • Catalysts with dates
  • Saved as a webpage in your account
  • Ready in 5–15 min (email when ready)

Full analysis at introductory pricing — 7-day money-back guarantee.

7-day money-back guarantee · No lock-in period · Secure payment via Stripe

Fact-based analysis Updated weekly No commitment period
The information on this page does not constitute investment advice. AI-generated analyses may contain errors. Always conduct your own research before making investment decisions. Firelda.ai is not responsible for any potential losses.